https://www.med.unc.edu/tarc/dr-rumey-ishizawars-research-finds-rheumatoid-arthritis-ra-patients-may-safely-receive-immune-checkpoint-inhibitors-icis-for-cancer-treatment/
Dr. Rumey Ishizawar's Research Finds Rheumatoid Arthritis (RA) Patients May Safely Receive Immune...
Apr 17, 2023 - The study evaluated whether pre-existing RA was associated with a higher mortality and risk for immune-related adverse events with ICI use.